This non-negotiable routine maximizes absorption but creates daily friction that some patients find manageable and others find incompatible with real life
Yes by reducing obesity, there is a correlation to the reduction in the prevalence of cardiovascular disease but there is still not enough cost-effectiveness for it to make sense for employers and insurance companies to cover medications like Semaglutide when used for weight-loss purposes
Wegovy is administered at a dose of 2.4 mg, while Ozempic is administered at a dose of 0.5 to 1 mg 5,6
You might tolerate the escalation fine
At current prices, even with recent reductions under the Trump administration's Most-Favored-Nation pricing initiative (bringing Ozempic and Wegovy to $350/month through TrumpRx, with a $50 Medicare co-pay), that's a significant long-term commitment
Patients should keep eating fewer calories and stay active to get the best result while titrating or adjusting the dose